AI Article Synopsis
- - The study focused on 37 local patients from the Amazon region who had left ventricular systolic dysfunction without a clear cause.
- - It aimed to determine how often chronic chagasic cardiopathy (CCC) occurred among these patients.
- - The results revealed that 3 out of the 37 patients were diagnosed with CCC, resulting in an 8.1% prevalence rate.
Article Abstract
This study assessed the frequency of chronic chagasic cardiopathy (CCC) in 37 autochthonus patients from Amazon region with left ventricular systolic dysfunction of undefined etiology. Three cases were diagnosed in the studied sample, with an 8.1% frequency.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/s0066-782x2009001200028 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ninoa Strain Modifies the Expression of microRNAs in Cardiac Tissue and Plasma During Chagas Disease Infection.
Pathogens
December 2024
Departamento de Inmunología, Instituto Nacional de Cardiología Ignacio Chávez (INCICH), Mexico City 14080, Mexico.
Chronic chagasic cardiomyopathy is the most severe clinical manifestation of Chagas disease, which affects approximately seven million people worldwide. Latin American countries bear the highest burden, with the greatest morbidity and mortality rates. Currently, diagnostic methods do not provide information on the risk of progression to severe stages of the disease.
View Article and Find Full Text PDFImmunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate.
PLoS Pathog
December 2024
Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
Trypanosoma cruzi is a protozoan parasite that causes Chagas disease. Globally 6 to 7 million people are infected by this parasite of which 20-30% will progress to develop Chronic Chagasic Cardiomyopathy (CCC). Despite its high disease burden, no clinically approved vaccine exists for the prevention or treatment of CCC.
View Article and Find Full Text PDFSerial 'deep-sampling' PCR of fragmented DNA reveals the wide range of burden among chronically infected hosts and allows accurate monitoring of parasite load following treatment.
bioRxiv
November 2024
Center for Tropical and Emerging Global Disease, University of Georgia, Athens, Georgia, USA.
Infection with the protozoan parasite is generally well-controlled by host immune responses, but appears to be rarely eliminated. The resulting persistent, low-level infection results in cumulative tissue damage with the greatest impact generally in the heart in the form of chagasic cardiomyopathy. The relative success in immune control of infection usually averts acute phase death but has the negative consequence that the low-level presence of in hosts is challenging to detect unequivocally.
View Article and Find Full Text PDFDifferential Regulation of L-Arginine Metabolism through NOS2 and Arginases during Infection with .
Pathogens
October 2024
Unidad de Investigación UNAM-INC, División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México-Instituto Nacional de Cardiología "Ignacio Chávez", Mexico City 14080, Mexico.
L-arginine metabolism through arginases and inducible nitric oxide synthase (NOS2) constitutes a fundamental axis for the resolution or progression of Chagas disease. Infection with can cause a wide spectrum of disease, ranging from acute forms contained by the host immune response to chronic ones, such as the chronic chagasic cardiomyopathy. Here, we analyzed, in an in vitro model, the ability of two isolates, with different degrees of virulence, to regulate the metabolism of L-arginine through arginase 1 (Arg-1) and NOS2 in macrophages and through arginase 2 (Arg-2) and NOS2 in cardiomyocytes.
View Article and Find Full Text PDFChronic Chagasic Cardiomyopathy: Influence of Physical Exercise.
Arq Bras Cardiol
October 2024
Departamento de Clínica Médica - Faculdade de Medicina de Botucatu - Universidade Estadual Paulista (UNESP), São Paulo, SP - Brasil.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!